Company intelligence / Profile preview

Rahn

Zürich, Switzerland

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Rahn is a Swiss-based, family-owned global supplier specializing in high-purity specialty chemicals and cosmetic actives used in energy curing (UV/EB) technologies, advanced 3D printing, and cosmetics. For healthcare, Rahn provides advanced raw materials (e.g., photoinitiators, monomers, oligomers) critical in high-performance 3D printing resins for medical devices and personalized medicine applications, but does not itself develop therapeutics or drugs[3][4].

Modalities: Small molecule (cosmetic actives)Monomer (resin components)Oligomer (resin components)Photoinitiator (enabling medical 3D printing)Additive (specialty functional for medical materials)
Industry: Chemicals & Materials

Partnerships

Walter Mäder AG (RadLab AG joint venture)Wide distributor/industry network in energy curing and cosmetics[5]

Beyond the preview

Go deeper on Rahn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rahn.

Explore the full profile